Kilitch Drugs (India) share news, announcements and annual reports
NSE: KILITCHBSE: 524500Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 30 Oct 2026. Previous close ₹209.14.
30 Oct: open ₹211.45, high ₹212.24, low ₹200.25
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹704 Cr1,776th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 23.42
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.52
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 12.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 8.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.32
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 34,67341.3% delivered
Kilitch Drugs (India) board meetings
156 filed, newest first. Page 2 of 4.
Feb 2021
11 Feb · Board meeting
4 Feb · Board meeting
Nov 2020
13 Nov · Board meeting
Sep 2020
15 Sep · Board meeting
Aug 2020
28 Aug · Board meeting
21 Aug · Board meeting
Jun 2020
30 Jun · Board meeting
25 Jun · Board meeting
May 2020
25 May · Board meeting
Feb 2020
14 Feb · Board meeting
Dec 2019
12 Dec · Board meeting
Nov 2019
13 Nov · Board meeting
Sep 2019
19 Sep · Board meeting
Aug 2019
22 Aug · Board meeting
19 Aug · Board meeting
13 Aug · Board meeting
6 Aug · Board meeting
May 2019
30 May · Board meeting
22 May · Board meeting
3 May · Board meeting
Apr 2019
Feb 2019
12 Feb · Board meeting
Nov 2018
7 Nov · Board meeting
Oct 2018
Aug 2018
31 Aug · Board meeting
13 Aug · Board meeting
Jun 2018
28 Jun · Board meeting
May 2018
25 May · Board meeting
17 May · Board meeting
Mar 2018
31 Mar · Board meeting
16 Mar · Board meeting
13 Mar · Board meeting
Feb 2018
14 Feb · Board meeting
Nov 2017
14 Nov · Board meeting
Sep 2017
15 Sep · Board meeting